mesenchymal stem cells (graft-versus-host disease)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemesenchymal stem cells (graft-versus-host disease)
Drug Alias NameImmuneSafe
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseMultiple Sclerosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCell2b
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCell2b
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGraft vs Host DiseaseMultiple Sclerosis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A